about
Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Beneficial catalytic immunity to abeta peptide.
@ast
Beneficial catalytic immunity to abeta peptide.
@en
Beneficial catalytic immunity to abeta peptide.
@nl
type
label
Beneficial catalytic immunity to abeta peptide.
@ast
Beneficial catalytic immunity to abeta peptide.
@en
Beneficial catalytic immunity to abeta peptide.
@nl
prefLabel
Beneficial catalytic immunity to abeta peptide.
@ast
Beneficial catalytic immunity to abeta peptide.
@en
Beneficial catalytic immunity to abeta peptide.
@nl
P2093
P2860
P356
P1476
Beneficial catalytic immunity to abeta peptide.
@en
P2093
Stephanie Planque
Sudhir Paul
Yasuhiro Nishiyama
P2860
P304
P356
10.1089/REJ.2009.0958
P407
P577
2010-04-01T00:00:00Z